BLK
BlackRock, Inc.
BLK has lower modeled downside risk, despite its lower overall score.
BPRN
Princeton Bancorp, Inc.
BPRN has a slight edge over BLK overall on the model score.
BLK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BLK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BLK.
BPRN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
BPRN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like BPRN.
BLK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 19x | $848 | -30% |
| Fair | 22x | $973 | -20% |
| Expensive | 26x | $1,149 | -5.5% |
| Current | 28x | $1,217 | — |
Historical ranges are pointers, not guarantees.
BLK has the edge over BPRN in the historical PE scenario, which offers more potential upside but is not a forecast.
BPRN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.2x | $24.43 | -45% |
| Fair | 12x | $34.48 | -22% |
| Forward | 12x | $44.45 | — |
| Expensive | 14x | $42.58 | -4.2% |
| Current | 15x | $44.45 | — |
Historical ranges are pointers, not guarantees.
BPRN's PE is in its expensive range at 15x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
BLK Forward outlook
There aren't enough analyst estimates for BLK to show an outlook.
BPRN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for BPRN, with profitability improving.
BLK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $43.87 | +11% |
| Q2 2026 | $41.73 | -0.4% |
| Q1 2026 | $39.73 | -4.7% |
| Q4 2025 | $35.31 | -17% |
| Q3 2025 | $39.42 | -2.7% |
| Q2 2025 | $41.89 | +4% |
| Q1 2025 | $41.69 | +5.9% |
| Q4 2024 | $42.53 | +16% |
BLK earned $43.87 per share over the past year, up 11% from the year before.
BPRN Earnings Per Share
BPRN and BLK do not have enough comparable growth data to identify a winner.
BLK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.8B | +19% |
| Q2 2026 | $7.1B | +31% |
| Q1 2026 | $6.7B | +27% |
| Q4 2025 | $7B | +23% |
| Q3 2025 | $6.5B | +25% |
| Q2 2025 | $5.4B | +13% |
| Q1 2025 | $5.3B | +12% |
| Q4 2024 | $5.7B | +23% |
BLK has the edge over BPRN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | 0 points |
| Q2 2026 | 35% | +2.8 points |
| Q1 2026 | 42% | +9.8 points |
| Q4 2025 | 24% | -13 points |
| Q3 2025 | 30% | -8.6 points |
| Q2 2025 | 32% | -5.5 points |
| Q1 2025 | 32% | -3.6 points |
| Q4 2024 | 37% | +2.3 points |
BLK has the edge over BPRN on profitability, with a higher operating margin.
BPRN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $22.5M | +4.4% |
| Q2 2026 | $22.5M | +6.7% |
| Q1 2026 | $21.3M | +1.7% |
| Q4 2025 | $20.7M | +3.6% |
| Q3 2025 | $21.5M | +12% |
| Q2 2025 | $21.1M | +17% |
| Q1 2025 | $20.9M | +20% |
| Q4 2024 | $20M | +13% |
BPRN's revenue has grown year over year for nine quarters in a row: $22M last quarter, up 4.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.7% | -33 points |
| Q2 2026 | 41% | +38 points |
| Q1 2026 | 38% | +4.9 points |
| Q4 2025 | 38% | +4.1 points |
| Q3 2025 | 38% | +68 points |
| Q2 2025 | 2.8% | -31 points |
| Q1 2025 | 33% | +1.8 points |
| Q4 2024 | 34% | -1.2 points |
BPRN's operating margin was 5.7% last quarter, down 33 points from the same quarter a year ago.
BLK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.6B | +95% |
| Q2 2026 | $1.1B | -12% |
| Q1 2026 | -$1.1B | +$120M |
| Q4 2025 | $2.1B | -15% |
| Q2 2025 | $1.3B | -6.1% |
| Q1 2025 | -$1.2B | -$734M |
| Q4 2024 | $2.5B | +35% |
| Q2 2024 | $1.4B | +47% |
BLK's free cash flow was $4.8B over the past year, up 22% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BLK.
BPRN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7M | +51% |
| Q2 2026 | $1.8M | -38% |
| Q1 2026 | $4.9M | +369% |
| Q4 2025 | $12M | +220% |
| Q3 2025 | $4.7M | +508% |
| Q2 2025 | $2.9M | -26% |
| Q1 2025 | $1.1M | -78% |
| Q4 2024 | $3.8M | +40% |
BPRN's free cash flow was $26M over the past year, up 108% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BPRN.
BLK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2024 | 0.2x | Very low |
| Q1 2024 | 0.3x | Very low |
| Q4 2023 | 0.1x | Very low |
BLK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BLK.
BPRN Net Leverage
BLK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.5 | Neutral |
| Stochastic | 79.0 | Neutral |
BLK's weekly RSI is 64 (neutral) and its Stochastic is 79 (neutral).
BPRN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.4 | Neutral |
| Stochastic | 57.8 | Neutral |
BPRN's weekly RSI is 63 (neutral) and its Stochastic is 58 (neutral).
BLK PE vs Financial Services Sector
| Metric | BLK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 13x | 113% above |
| PE % | 97 | 63 | 34 pts above |
BLK is trading at 28x earnings, a 113% premium to the Financial Services sector's median of 13x.
BPRN PE vs Financial Services Sector
| Metric | BPRN | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 14% above |
| PE % | 88 | 63 | 25 pts above |
BPRN has the edge over BLK on valuation relative to its sector.
BLK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,128.0 | 7.9% above |
| 20 week MA | $1,108.9 | 9.7% above |
| 50 week MA | $1,071.6 | 14% above |
| 100 week MA | $1,051.1 | 16% above |
| 200 week MA | $914.1 | 33% above |
BLK is in an uptrend: it's above all five of its weekly moving averages, and 33% above its 200-week average.
BPRN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $43.9 | 1.3% above |
| 20 week MA | $42.5 | 4.7% above |
| 50 week MA | $38.2 | 16% above |
| 100 week MA | $35.0 | 27% above |
| 200 week MA | $33.7 | 32% above |
BPRN is in an uptrend: it's above all five of its weekly moving averages, and 32% above its 200-week average.
BLK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $503.0 | $707.2 | +41% |
| 2021 | $707.2 | $913.9 | +29% |
| 2022 | $913.9 | $703.9 | -23% |
| 2023 | $703.9 | $811.8 | +15% |
| 2024 | $811.8 | $1,044.2 | +29% |
| 2025 | $1,044.2 | $1,088.1 | +4.2% |
| 2026 YTD | $1,088.1 | $1,216.6 | +12% |
BLK has finished higher in five of the last six years. It's up 12% so far in 2026.
BPRN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.9 | $23.6 | -26% |
| 2021 | $23.6 | $29.2 | +23% |
| 2022 | $29.2 | $31.6 | +8.2% |
| 2023 | $31.6 | $35.9 | +14% |
| 2024 | $35.9 | $34.4 | -4.3% |
| 2025 | $34.4 | $35.3 | +2.7% |
| 2026 YTD | $35.3 | $44.5 | +26% |
BPRN has the edge over BLK on returns for 2026, with the stronger performance.